Camber Spine has launched SPIRA- C Integrated Interbody system and the FORTICO Anterior Cervical Plating System after obtaining clearance from the US Food and Drug Administration (FDA).
SPIRA- C Integrated Interbody system is a cervical fixation device and Fortico is a two-screw plating system intended for anterior screw fixation to the cervical spine (C2-T1) in skeletally mature patients.
The open architecture design of SPIRA- C is claimed to provide the spine surgeons with a zero profile, screw fixated interbody option for anterior cervical fusions.
FORTICO is a low profile cervical plate developed to match the anterior face of the SPIRA interbody system. It can be attached to the interbody cage or used independently.
The SPIRA-C Integrated incorporates the company’s proprietary technology Surface by Design. This technology is designed to optimise endplate contact and promote arthrodesis.
Camber Spine chief innovation officer Seth Anderson said: “Camber Spine has spent the last year in aggressive development to create two options for spine surgeons to address anterior cervical pathology.
“These two additions will establish Camber Spine as a new leader in 3D printed, arched, open architecture cervical implants and cervical fixation options for the treatment of complex spine pathologies.”
The company recently received additional issued patents from the US Patent and Trademark Office on the SPIRA technology. This is expected to further strengthen its position in the open architecture 3D printed implant space.
The company noted that several clinical studies are being carried out at prestigious spine centres to prove the efficacy of SPIRA technology as open architecture cage.